Bill Text: NJ S1870 | 2010-2011 | Regular Session | Introduced
Bill Title: Requires physician practices that provide intravenous therapies in medical office to register with DHSS.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2010-05-10 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1870 Detail]
Download: New_Jersey-2010-S1870-Introduced.html
Sponsored by:
Senator ROBERT W. SINGER
District 30 (Burlington, Mercer, Monmouth and Ocean)
SYNOPSIS
Requires physician practices that provide intravenous therapies in medical office to register with DHSS.
CURRENT VERSION OF TEXT
As introduced.
An Act concerning regulation of office-based intravenous therapies and supplementing Title 26 of the Revised Statutes.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. Notwithstanding the provisions of any other law to the contrary, a physician's medical office at which intravenous therapy, including chemotherapy and hemotherapy, is performed on patients in the physician's office, shall register with the Department of Health and Senior Services within one year of the effective date of this act as an intravenous therapy practice.
b. As a condition of registration with the department, an intravenous therapy practice shall be required to report the following information annually: the number of patients who received intravenous therapy at the physician's medical office and the number of patient visits.
c. (1) The Commissioner of Health and Senior Services shall require an applicant for registration as an intravenous therapy practice to submit an application for registration in a form and manner prescribed by the department. The applicant shall submit the name and address of the therapy practice that is to be registered, the name of the chief administrator or designated agent of the practice, the names and addresses of all owners of the practice, the scope of services provided at the practice, and such other information as the commissioner deems necessary and as provided by regulation.
(2) The registration shall be valid for a one-year period and may be renewed upon submission to the department of an application for renewal.
(3) The commissioner may suspend, revoke, or deny a registration if the registrant or applicant, as applicable, is not in compliance with the requirements of this section.
(4) No registered intravenous therapy practice shall be owned, managed, or operated by any person convicted of a crime relating adversely to the person's capability of owning, managing, or operating the practice.
(5) The department may charge a reasonable fee for filing an application for registration and for each renewal thereof.
d. The commissioner shall require that each registered intravenous therapy practice is inspected annually by the department or an agency designated by the commissioner to ensure compliance with the infection prevention and control procedures established pursuant to this act. The commissioner may designate the applicable local health agency to conduct the inspection, and the department or designated agency may charge a reasonable fee for the inspection.
e. The commissioner shall, pursuant to the "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), adopt rules and regulations setting forth infection prevention and control procedures to which an intravenous therapy practice shall be required to comply and such other requirements as the commissioner deems appropriate.
f. Nothing in this act shall be construed to limit the State Board of Medical Examiners from establishing standards of care with respect to the practice of medicine.
2. This act shall take effect one year after the date of enactment of this act, but the Commissioner of Health and Senior Services may take such anticipatory administrative action in advance thereof as shall be necessary for the implementation of this act.
STATEMENT
This bill would require a physician's medical office at which intravenous therapy, including chemotherapy and hemotherapy, is performed on patients in the physician's office, to register with the Department of Health and Senior Services within one year of the effective date of this bill as an intravenous therapy practice. The purpose of this bill is to ensure that medical practices that provide intravenous oncology and hematology therapies maintain uniform infection prevention and control procedures to ensure the health and safety of patients treated in a physician's office.
Specifically, the bill provides as follows:
· As a condition of registration with the department, an intravenous therapy practice shall be required to annually report: the number of patients who received intravenous therapy at the physician's medical office and the number of patient visits.
· An applicant for registration as an intravenous therapy practice shall submit an application for registration in a form and manner prescribed by the Commissioner of Health and Senior Services. The applicant shall submit the name and address of the therapy practice that is to be registered, the name of the chief administrator or designated agent of the practice, the names and addresses of all owners of the practice, the scope of services provided at the practice, and such other information as the commissioner deems necessary and as provided by regulation. The registration shall be valid for a one-year period and may be renewed upon submission to the department of an application for renewal. The department may charge a reasonable fee for filing an application for registration and for each renewal thereof.
· The commissioner may suspend, revoke, or deny a registration if the registrant or applicant, as applicable, is not in compliance with the requirements of the bill.
· No registered intravenous therapy practice shall be owned, managed, or operated by any person convicted of a crime relating adversely to the person's capability of owning, managing, or operating the practice.
· Each registered intravenous therapy practice shall be inspected annually by the department or an agency designated by the commissioner to ensure compliance with the infection prevention and control procedures established pursuant to this bill. The commissioner may designate the applicable local health agency to conduct the inspection, and the department or designated agency may charge a reasonable fee for the inspection.
· The commissioner shall adopt rules and regulations setting forth infection prevention and control procedures to which an intravenous therapy practice shall be required to comply and such other requirements as the commissioner deems appropriate.
· Nothing in this bill shall be construed to limit the State Board of Medical Examiners from establishing standards of care with respect to the practice of medicine.
· The bill takes effect one year after the date of enactment of this act, but the commissioner may take such anticipatory administrative action in advance thereof as shall be necessary for its implementation.
